# WaferGen Bio-systems, Inc.

WaferGen Bio-systems, Inc. is a company headquartered in Fremont, CA, United States.

## Company overview

- **Legal name:** WaferGen Bio-systems, Inc.
- **Former names in filing history:** La Burbuja Cafe, Inc. (2006-08-09 to 2007-02-01)
- **Classification:** Company
- **Industry (SIC):** 3826 — Laboratory Analytical Instruments
- **Headquarters:** Fremont, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001368993

## About

WaferGen Bio-systems, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001368993, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2016-03-25, it reported annual revenue of USD 7,167,000; net income of USD -15,315,000; total assets of USD 22,873,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $7.2M (USD 7,167,000)
- **Net income:** -$15.3M (USD -15,315,000)
- **Total assets:** $22.9M (USD 22,873,000)
- **Cash and equivalents:** $15.2M (USD 15,236,000)
- **Operating cash flow:** -$14.6M (USD -14,638,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $6.0M (USD 6,001,342)
- **Net income:** -$10.7M (USD -10,692,863)
- **Total assets:** $20.7M (USD 20,706,980)
- **Cash and equivalents:** $14.7M (USD 14,732,107)
- **Operating cash flow:** -$10.3M (USD -10,287,401)
- **Later filings:** Revenue, Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $1.3M (USD 1,304,747)
- **Net income:** -$16.3M (USD -16,266,272)
- **Total assets:** $12.0M (USD 12,030,929)
- **Cash and equivalents:** $10.7M (USD 10,708,646)
- **Operating cash flow:** -$8.2M (USD -8,221,214)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $586,176 (USD 586,176)
- **Net income:** -$8.2M (USD -8,176,662)
- **Total assets:** $8.9M (USD 8,897,458)
- **Cash and equivalents:** $6.3M (USD 6,328,753)
- **Operating cash flow:** -$8.9M (USD -8,867,888)

## Recent SEC filings

- Form 8-K — filed 2017-03-01 — period 2017-02-28 — 8-K
- Form 8-K — filed 2017-02-15 — period 2017-02-15 — 8-K
- Form 8-K — filed 2016-11-28 — period 2016-11-22 — 8-K
- Form SC 13G — filed 2016-11-28
- Form SC 13G — filed 2016-11-28
- Form 8-K — filed 2016-11-15 — period 2016-11-15 — 8-K
- Form 10-Q — filed 2016-11-10 — period 2016-09-30 — 10-Q
- Form 8-K — filed 2016-11-08 — period 2016-11-08 — 8-K
- Form 8-K — filed 2016-10-31 — period 2016-10-31 — 8-K
- Form 8-K — filed 2016-10-28 — period 2016-10-28 — 8-K
- Form 8-K — filed 2016-10-27 — period 2016-10-26 — 8-K
- Form 10-Q — filed 2016-08-11 — period 2016-06-30 — 10-Q

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/wafergen-bio-systems-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology